Ideagen : FY22 Interim Presentation

Interim Results FY21-22

January '22

Contents

01 Investment Case

02 What we do

03 3 Year Strategy

04 Financial Performance

05 Funding Growth

06 Golden KPIs

07 M&A

08 Market Overview

09 Summary

Interim Results FY21-22

Investment Case

$30bn+ market	Accelerating structural	Good revenue visibility,
opportunity	growth drivers	high quality of earnings

12 years of profitable	Organic growth	A growing team
growth, strong cash	and M&A in a	of experts
generation	fragmented market

Interim Results FY21-22

3

What we do

Our Purpose		Our Products
To make complying with regulation easy, quick and cost effective		A suite of user-friendly, reliable and cost-effective software

QHSE	RCA	Collaboration
Quality - Health - Safety - Environment	Risk - Compliance - Audit	Regulated Collaboration

250 hospitals		300+ Aviation		9 of the top 10		7 of the top global		15 of the top 20
in the UK and US		organisations globally		accounting firms		aerospace defence companies		pharma companies

Select

Clients

Interim Results FY21-22

4

Become a global leader in Governance, Risk & Compliance software. At the heart of conscious organisations, contributing where it matters.

Organic Growth

• Focus on new customer acquisition in core geographies and vertical markets
• Improve upsell to existing customer portfolio through improved product integration

M&A Strategy

• Adjacent capabilities and geographical expansion
• Maintain M&A discipline
• Value, Growth, Culture
• Actively integrate in to core pillars

Interim Results FY21-22

5